Adrenocortical carcinoma is a cancer of the adrenal glands.
Alternative Names
Tumor - adrenal
Causes, incidence, and risk factors
Adrenocortical carcinoma is most common in children younger than 5 and adults in their 30s and 40s.
Adrenocortical carcinoma may be linked to a cancer syndrome that is passed down through families (inherited). Both men and women can develop this tumor.
Adrenocortical carcinoma can produce the hormones cortisol, aldosterone, estrogen, or testosterone, as well as other hormones. In women the tumor often releases these hormones, which can lead to male characteristics.
The cause is unknown. About 2 people per million develop this type of tumor.
Symptoms
Symptoms that suggest increased cortisol or other adrenal gland hormone production:
Fatty, rounded hump high on the back just below the neck (buffalo hump)
Flushed rounded face with pudgy cheeks (moon face)
Virilization - the appearance of male characteristics, including increased body hair (especially on the face), pubic hair, acne, deepening of voice, and enlarged clitoris (girls)
Symptoms that suggest increased aldosterone production are the same as symptoms of low potassium and include:
Muscle cramps
Weakness
Signs and tests
The doctor or nurse will examine you. You may have high blood pressure and changes in body shape, such as breast growth in men (gynecomastia) or male signs in women (virilization). Blood tests will be done to check hormone levels:
Primary treatment is surgery to remove the tumor. Adrenocortical carcinoma may not improve with chemotherapy. Medications may be given to reduce production of cortisol, which causes many of the symptoms.
Expectations (prognosis)
The outcome depends on how early the diagnosis is made and whether the tumor has spread (metastasized). Tumors that have spread usually lead to death within 1 to 3 years.
Complications
The tumor can spread to the liver, bone, lung, or other areas.
Calling your health care provider
Call your health care provider if you or your child has symptoms of adrenocortical carcinoma, Cushing syndrome, or failure to grow.
References
National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Neuroendocrine tumors. 2012. Version 1.2012.
Review Date:
8/30/2012
Reviewed By:
David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
